F · Healthcare

Rhythm Biosciences Limited (0RY)

Diagnostics & Research

Rhythm Biosciences Limited (0RY) is listed on F in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 0RY

P/E ratio

18.00

Rhythm Biosciences Limited (0RY) — FAQ

What is 0RY's P/E ratio?

The price-to-earnings (P/E) ratio for Rhythm Biosciences Limited (0RY) is 18.00 (data as of 2026-03-22).

Does Rhythm Biosciences Limited pay a dividend?

Dividend yield is not available in the current snapshot for Rhythm Biosciences Limited (0RY). Check the MyAverix Finance app for the latest dividend data.

What sector is Rhythm Biosciences Limited in?

Rhythm Biosciences Limited (0RY) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is 0RY listed on?

0RY is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)